Paramyxovirus vector encoding angiogenesis gene and use thereof

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 48/00 (2006.01) C07K 14/50 (2006.01)

Patent

CA 2430112

The present invention provides Paramyxovirus vectors encoding angiogenic genes and use of the same. The use of Paramyxovirus vectors enables effective transfer of angiogenic genes into individual tissues. FGF2 gene transferred into ischemic tissues in vivo induces expression of angiogenic genes without causing edema, and prevents necrosis due to ischemia. The vectors of the present invention are suitable for gene therapy targeted to ischemic tissues.

L'invention concerne un vecteur paramyxovirus codant pour un gène angiogénèse. L'utilisation du vecteur paramyxovirus permet de transférer efficacement le gène angiogénèse dans un tissu individuel. Le gène FGF2 administré in vivo exprime le gène angiogénèse n'entraînant aucun oedème dans un tissu ischémique, ce qui permet de prévenir la nécrose due à l'ischémie. L'utilisation de ce vecteur convient bien en thérapie génique ciblant les tissus ischémiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Paramyxovirus vector encoding angiogenesis gene and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Paramyxovirus vector encoding angiogenesis gene and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Paramyxovirus vector encoding angiogenesis gene and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1770901

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.